Egypt-based B2B Healthtech 30Med has raised pre-Seed funding from undisclosed angel investors. The new funding should provide the company with the necessary resources to further develop its platform and expand its reach within the medical community.

Founded in 2023 by Ayman Ragab, 30Med aims to bridge the gap between pharmaceutical companies and physicians by providing interactive videos and conference events that showcase new medicines and facilitate ongoing learning. The platform boasts a substantial user base, comprising doctors who are eager to stay informed and engaged with the latest advancements in medicine and pharmaceuticals. 

The post Egyptian Healthtech 30Med Secures Pre-Seed Round appeared first on WeeTracker.